查看中文
xxu@cooley.com
Xiaoyu Xu focuses her practice in the areas of initial public offerings, venture capital investment, mergers and acquisitions, and general corporate matters.
Download full bio
Keymed Biosciences – HK$3.1 Billion IPO
Capital Markets
Venture Capital
Mergers & Acquisitions
Life Sciences
Asia
Columbia University LLM
University of International Business and EconomicsLLB
New York
Keymed Biosciences – HK$3.1 Billion IPO July 8, 2021
+86 10 8540 0652
Locations